APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Knee Osteoarthritis Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Knee Osteoarthritis Treatment Industry Growth and Trends Forecast to 2032

Report ID 174005990120 December 2025101 pages

Choose your research edition.

Industry ResearchKnee Osteoarthritis Treatment Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Knee Osteoarthritis Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Knee Osteoarthritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Knee Osteoarthritis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Knee Osteoarthritis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Knee Osteoarthritis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Knee Osteoarthritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Knee Osteoarthritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Knee Osteoarthritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Knee Osteoarthritis Treatment market include Anika Therapeutics, AVM Biotechnology, Bioventus, Flexion Therapeutics, Horizon Therapeutics, OrthoTrophix, Bayer, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Knee Osteoarthritis Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Knee Osteoarthritis Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Knee Osteoarthritis Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Knee Osteoarthritis Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Knee Osteoarthritis Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Knee Osteoarthritis Treatment Market by Company

Anika Therapeutics

AVM Biotechnology

Bioventus

Flexion Therapeutics

Horizon Therapeutics

OrthoTrophix

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly

Johnson and Johnson

Sanofi

Abbott

Knee Osteoarthritis Treatment Segment by Type

Non-surgical Treatment

Surgical Treatment

Knee Osteoarthritis Treatment Segment by Application

Ambulatory Surgical Centers

Hospitals

Specialty Clinics

Others

Knee Osteoarthritis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Knee Osteoarthritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Knee Osteoarthritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Knee Osteoarthritis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Knee Osteoarthritis Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Knee Osteoarthritis Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Knee Osteoarthritis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Knee Osteoarthritis Treatment Market Share by Region (2021-2026) Table 4. Global Knee Osteoarthritis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Knee Osteoarthritis Treatment Market Share by Region (2027-2032) Table 6. Global Knee Osteoarthritis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Knee Osteoarthritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Knee Osteoarthritis Treatment Market Size Share by Type (2021-2026) Table 9. Global Knee Osteoarthritis Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Knee Osteoarthritis Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Knee Osteoarthritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Knee Osteoarthritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Knee Osteoarthritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Knee Osteoarthritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Knee Osteoarthritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Knee Osteoarthritis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Knee Osteoarthritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Knee Osteoarthritis Treatment Market Size Share by Application (2021-2026) Table 24. Global Knee Osteoarthritis Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Knee Osteoarthritis Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Knee Osteoarthritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Knee Osteoarthritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Knee Osteoarthritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Knee Osteoarthritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Knee Osteoarthritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Knee Osteoarthritis Treatment Industry Trends Table 37. Knee Osteoarthritis Treatment Industry Drivers Table 38. Knee Osteoarthritis Treatment Industry Opportunities and Challenges Table 39. Knee Osteoarthritis Treatment Industry Restraints Table 40. Global Knee Osteoarthritis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Knee Osteoarthritis Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Knee Osteoarthritis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Knee Osteoarthritis Treatment Key Company Headquarters & Area Served Table 44. Global Knee Osteoarthritis Treatment Company, Product Type & Application Table 45. Global Knee Osteoarthritis Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Knee Osteoarthritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Anika Therapeutics Company Information Table 49. Anika Therapeutics Business Overview Table 50. Anika Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Anika Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 52. Anika Therapeutics Recent Development Table 53. AVM Biotechnology Company Information Table 54. AVM Biotechnology Business Overview Table 55. AVM Biotechnology Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. AVM Biotechnology Knee Osteoarthritis Treatment Product Portfolio Table 57. AVM Biotechnology Recent Development Table 58. Bioventus Company Information Table 59. Bioventus Business Overview Table 60. Bioventus Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bioventus Knee Osteoarthritis Treatment Product Portfolio Table 62. Bioventus Recent Development Table 63. Flexion Therapeutics Company Information Table 64. Flexion Therapeutics Business Overview Table 65. Flexion Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Flexion Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 67. Flexion Therapeutics Recent Development Table 68. Horizon Therapeutics Company Information Table 69. Horizon Therapeutics Business Overview Table 70. Horizon Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Horizon Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 72. Horizon Therapeutics Recent Development Table 73. OrthoTrophix Company Information Table 74. OrthoTrophix Business Overview Table 75. OrthoTrophix Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. OrthoTrophix Knee Osteoarthritis Treatment Product Portfolio Table 77. OrthoTrophix Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bayer Knee Osteoarthritis Treatment Product Portfolio Table 82. Bayer Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Knee Osteoarthritis Treatment Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pfizer Knee Osteoarthritis Treatment Product Portfolio Table 92. Pfizer Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eli Lilly Knee Osteoarthritis Treatment Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Johnson and Johnson Company Information Table 99. Johnson and Johnson Business Overview Table 100. Johnson and Johnson Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Johnson and Johnson Knee Osteoarthritis Treatment Product Portfolio Table 102. Johnson and Johnson Recent Development Table 103. Sanofi Company Information Table 104. Sanofi Business Overview Table 105. Sanofi Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sanofi Knee Osteoarthritis Treatment Product Portfolio Table 107. Sanofi Recent Development Table 108. Abbott Company Information Table 109. Abbott Business Overview Table 110. Abbott Knee Osteoarthritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Abbott Knee Osteoarthritis Treatment Product Portfolio Table 112. Abbott Recent Development Table 113. North America Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Knee Osteoarthritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Knee Osteoarthritis Treatment Market Share by Country (2021-2026) Table 116. North America Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Knee Osteoarthritis Treatment Market Share Forecast by Country (2027-2032) Table 118. Europe Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Knee Osteoarthritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Knee Osteoarthritis Treatment Market Share by Country (2021-2026) Table 121. Europe Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Knee Osteoarthritis Treatment Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Knee Osteoarthritis Treatment Market Share by Country (2021-2026) Table 126. Asia-Pacific Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Knee Osteoarthritis Treatment Market Share Forecast by Country (2027-2032) Table 128. Latin America Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Knee Osteoarthritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Knee Osteoarthritis Treatment Market Share by Country (2021-2026) Table 131. Latin America Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Knee Osteoarthritis Treatment Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Knee Osteoarthritis Treatment Market Share by Country (2021-2026) Table 136. Middle East & Africa Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Knee Osteoarthritis Treatment Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Knee Osteoarthritis Treatment Product Image Figure 3. Global Knee Osteoarthritis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Knee Osteoarthritis Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Knee Osteoarthritis Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Knee Osteoarthritis Treatment Market Share by Region (2021-2032) Figure 7. North America Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Non-surgical Treatment Image Figure 13. Global Non-surgical Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Surgical Treatment Image Figure 15. Global Surgical Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Knee Osteoarthritis Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Knee Osteoarthritis Treatment Market Share by Type 2025 VS 2032 Figure 18. North America Knee Osteoarthritis Treatment Market Size Share by Type (2021-2032) Figure 19. Europe Knee Osteoarthritis Treatment Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Knee Osteoarthritis Treatment Market Size Share by Type (2021-2032) Figure 21. Latin America Knee Osteoarthritis Treatment Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Knee Osteoarthritis Treatment Market Size Share by Type (2021-2032) Figure 23. Ambulatory Surgical Centers Image Figure 24. Global Ambulatory Surgical Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Hospitals Image Figure 26. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Specialty Clinics Image Figure 28. Global Specialty Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Knee Osteoarthritis Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Knee Osteoarthritis Treatment Market Share by Application 2025 VS 2032 Figure 33. North America Knee Osteoarthritis Treatment Market Size Share by Application (2021-2032) Figure 34. Europe Knee Osteoarthritis Treatment Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Knee Osteoarthritis Treatment Market Size Share by Application (2021-2032) Figure 36. Latin America Knee Osteoarthritis Treatment Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Knee Osteoarthritis Treatment Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Knee Osteoarthritis Treatment Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Knee Osteoarthritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Knee Osteoarthritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Knee Osteoarthritis Treatment Market Share by Country (2021-2032) Figure 43. Europe Knee Osteoarthritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Knee Osteoarthritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Knee Osteoarthritis Treatment Market Share by Country (2021-2032) Figure 46. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Knee Osteoarthritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Knee Osteoarthritis Treatment Market Share by Country (2021-2032) Figure 49. Latin America Knee Osteoarthritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Knee Osteoarthritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Knee Osteoarthritis Treatment Market Share by Country (2021-2032) Figure 52. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Knee Osteoarthritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Knee Osteoarthritis Treatment Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Non-surgical Treatment
  • Surgical Treatment
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
  • Others
Companies covered
  • Anika Therapeutics
  • AVM Biotechnology
  • Bioventus
  • Flexion Therapeutics
  • Horizon Therapeutics
  • OrthoTrophix
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Johnson and Johnson
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Knee Osteoarthritis Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Knee Osteoarthritis Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Knee Osteoarthritis Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Knee Osteoarthritis Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Knee Osteoarthritis Treatment Market Size (2021-2032)
  8. 1.5.1 North America Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate (2021-2032)
2 Knee Osteoarthritis Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Non-surgical Treatment
  3. 2.1.2 Surgical Treatment
  4. 2.2 Global Knee Osteoarthritis Treatment Market Size by Type
  5. 2.2.1 Global Knee Osteoarthritis Treatment Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Knee Osteoarthritis Treatment Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Knee Osteoarthritis Treatment Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Knee Osteoarthritis Treatment Market Size by Regions
  9. 2.3.1 North America Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Knee Osteoarthritis Treatment Market Size Breakdown by Type (2021-2026)
3 Knee Osteoarthritis Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Ambulatory Surgical Centers
  3. 3.1.2 Hospitals
  4. 3.1.3 Specialty Clinics
  5. 3.1.4 Others
  6. 3.2 Global Knee Osteoarthritis Treatment Market Size by Application
  7. 3.2.1 Global Knee Osteoarthritis Treatment Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Knee Osteoarthritis Treatment Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Knee Osteoarthritis Treatment Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Knee Osteoarthritis Treatment Market Size by Regions
  11. 3.3.1 North America Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Knee Osteoarthritis Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Knee Osteoarthritis Treatment Industry Trends
  2. 4.2 Knee Osteoarthritis Treatment Industry Drivers
  3. 4.3 Knee Osteoarthritis Treatment Industry Opportunities and Challenges
  4. 4.4 Knee Osteoarthritis Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Knee Osteoarthritis Treatment Revenue (2021-2026)
  2. 5.2 Global Knee Osteoarthritis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Knee Osteoarthritis Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Knee Osteoarthritis Treatment Company, Product Type & Application
  5. 5.5 Global Knee Osteoarthritis Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Knee Osteoarthritis Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Knee Osteoarthritis Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Knee Osteoarthritis Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Anika Therapeutics
  2. 6.1.1 Anika Therapeutics Company Information
  3. 6.1.2 Anika Therapeutics Business Overview
  4. 6.1.3 Anika Therapeutics Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Anika Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  6. 6.1.5 Anika Therapeutics Recent Developments
  7. 6.2 AVM Biotechnology
  8. 6.2.1 AVM Biotechnology Company Information
  9. 6.2.2 AVM Biotechnology Business Overview
  10. 6.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Product Portfolio
  12. 6.2.5 AVM Biotechnology Recent Developments
  13. 6.3 Bioventus
  14. 6.3.1 Bioventus Company Information
  15. 6.3.2 Bioventus Business Overview
  16. 6.3.3 Bioventus Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bioventus Knee Osteoarthritis Treatment Product Portfolio
  18. 6.3.5 Bioventus Recent Developments
  19. 6.4 Flexion Therapeutics
  20. 6.4.1 Flexion Therapeutics Company Information
  21. 6.4.2 Flexion Therapeutics Business Overview
  22. 6.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  24. 6.4.5 Flexion Therapeutics Recent Developments
  25. 6.5 Horizon Therapeutics
  26. 6.5.1 Horizon Therapeutics Company Information
  27. 6.5.2 Horizon Therapeutics Business Overview
  28. 6.5.3 Horizon Therapeutics Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Horizon Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  30. 6.5.5 Horizon Therapeutics Recent Developments
  31. 6.6 OrthoTrophix
  32. 6.6.1 OrthoTrophix Company Information
  33. 6.6.2 OrthoTrophix Business Overview
  34. 6.6.3 OrthoTrophix Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 OrthoTrophix Knee Osteoarthritis Treatment Product Portfolio
  36. 6.6.5 OrthoTrophix Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Knee Osteoarthritis Treatment Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Knee Osteoarthritis Treatment Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Knee Osteoarthritis Treatment Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Eli Lilly
  56. 6.10.1 Eli Lilly Company Information
  57. 6.10.2 Eli Lilly Business Overview
  58. 6.10.3 Eli Lilly Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eli Lilly Knee Osteoarthritis Treatment Product Portfolio
  60. 6.10.5 Eli Lilly Recent Developments
  61. 6.11 Johnson and Johnson
  62. 6.11.1 Johnson and Johnson Company Information
  63. 6.11.2 Johnson and Johnson Business Overview
  64. 6.11.3 Johnson and Johnson Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Johnson and Johnson Knee Osteoarthritis Treatment Product Portfolio
  66. 6.11.5 Johnson and Johnson Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Knee Osteoarthritis Treatment Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
  73. 6.13 Abbott
  74. 6.13.1 Abbott Company Information
  75. 6.13.2 Abbott Business Overview
  76. 6.13.3 Abbott Knee Osteoarthritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Abbott Knee Osteoarthritis Treatment Product Portfolio
  78. 6.13.5 Abbott Recent Developments
7 North America
  1. 7.1 North America Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Knee Osteoarthritis Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst